According to Dr Gust H Bardy (Seattle Institute for Cardiac Research, WA), if the device (S-ICD®, Cameron Health) becomes broadly available, it could potentially help avoid some of the disadvantages ...
May 5, 2011 (San Francisco, California) — Burgeoning experience with an implantable cardioverter-defibrillator (ICD) that has an entirely subcutaneous lead system (S-ICD, Cameron Health, San Clemente, ...
Implantable cardioverter-defibrillators (ICDs) reduce mortality in patients with increased risk of sudden cardiac death, but use of these devices has been limited by complications with the ...
Please provide your email address to receive an email when new articles are posted on . Among patients who received implantable cardioverter defibrillator therapy, a subcutaneous vs. transvenous ...
Implantable cardioverter–defibrillators (ICDs) prevent sudden death from cardiac causes in selected patients but require the use of transvenous lead systems. To eliminate the need for venous access, ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- ...
Transvenous leads are the most common source of complications associated with the use of implantable cardioverter-defibrillators (ICDs). A preliminary experience with an entirely subcutaneous ICD ...
Please provide your email address to receive an email when new articles are posted on . Transvenous ICD leads are associated with tricuspid regurgitation compared with subcutaneous ICDs. More research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results